AI Model for Bone Mineral Density Prediction From X-Ray Images
Development and Evaluation of an Artificial Intelligence Model for Bone Mineral Density Prediction From X-Ray Images
2 other identifiers
observational
600
1 country
1
Brief Summary
Osteoporosis, a pervasive skeletal disorder characterized by diminished bone strength predisposing individuals to an increased risk of fractures, presents a substantial public health challenge globally. It's estimated that osteoporosis and its consequent increase in fracture risk significantly contribute to morbidity, mortality, and economic costs. Despite the availability of effective treatments, the condition often remains undiagnosed and untreated until a fracture occurs, underscoring the critical need for early detection and intervention. Dual-energy X-ray absorptiometry (DEXA) is the gold standard for assessing bone mineral density (BMD) and fracture risk. However, its utility is hampered by limited availability, especially in rural and low-resource settings, such as Bangladesh, where osteoporosis prevalence is notably high. The scarcity of DEXA units exacerbates the challenge of osteoporosis screening and management, leaving a significant portion of the population at risk In this context, plain X-ray imaging, widely available even in resource-constrained settings, emerges as a promising alternative for osteoporosis screening. Recent advancements in deep learning and computer vision offer the potential to automate the analysis of X-ray images for BMD estimation. The primary objective is to curate a comprehensive dataset of X-ray images of hip and spine as well as BMD reports and relevant clinical information sourced from local health facilities in Bangladesh encompassing diverse demographic data. The objective of this thesis is to develop and evaluate an Artificial Intelligence (AI)-based model that predicts BMD from plain X-ray images of the lumbar spine and pelvis. The proposed AI model processes X-ray images to detect subtle changes in bone texture and density, potentially offering a rapid, non-invasive, and cost-effective tool for large-scale osteoporosis screening, particularly beneficial in regions like Bangladesh where DEXA is scarcely available. This research addresses the critical gap in osteoporosis screening and diagnosis, aiming to contribute significantly to public health by enabling earlier detection and management of osteoporosis, thereby reducing the incidence of fractures and associated healthcare costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2024
CompletedFirst Submitted
Initial submission to the registry
October 16, 2024
CompletedFirst Posted
Study publicly available on registry
October 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 12, 2025
CompletedOctober 22, 2024
October 1, 2024
6 months
October 16, 2024
October 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone Mineral Density (BMD) - Hip and Spinal (L1-L4)
Measurement of bone mineral density in the hip and spinal regions (L1-L4) as an indicator for assessing bone strength. The BMD values will be used as key metrics to train the AI model for predicting osteoporosis risk from x-ray data.
Day 1
Secondary Outcomes (2)
WHO Classification (Normal, Low Bone Mass, Osteoporosis)
Through study completion, an average of 6 months
Fracture risk assessment
Through study completion, an average of 6 months
Study Arms (1)
Patients presenting for DEXA scan
The study group consists of patients presenting for Bone Mineral Density (BMD) testing using DEXA scans in the Radiology Department, as well as those with available spine and hip X-ray images. This group includes individuals with suspected osteoporosis referred for a BMD test by an attending orthopedic specialist, along with patients undergoing routine testing. The group encompasses a diverse demographic, including males, premenopausal women, and postmenopausal women across various age groups. This diversity enables the evaluation of the AI model across a broad range of conditions and patient backgrounds, enhancing its generalizability and clinical utility.
Interventions
A DEXA scan, or Dual-Energy X-ray Absorptiometry, is a specialized imaging technique used to measure Bone Mineral Density (BMD). It is commonly employed to diagnose osteoporosis and assess the risk of fractures, especially in areas prone to bone density loss, such as the spine, hip, and forearm. The scan works by using two low-energy X-ray beams that pass through the bone, allowing it to differentiate between bone and soft tissue and calculate the bone's density. DEXA is considered the gold standard for osteoporosis diagnosis due to its high accuracy and precision. The DEXA scan is a non-invasive, out-patient and painless procedure. Patients lie on an examination table while the scanner passes over the targeted area, typically the hip and spine. The entire procedure is straightforward, taking around 10 to 30 minutes depending on the areas being scanned.
Hip and spine X-rays are specific types of radiographic imaging used primarily to evaluate bone health, joint integrity, and alignment in these crucial areas. In the context of osteoporosis assessment, hip and spine X-rays can reveal signs of bone thinning or fractures, serving as an initial screening tool before more detailed imaging like a DEXA scan. During a hip X-ray, the patient typically lies on an examination table with the hip positioned for a clear view of the pelvis and femur. In a spine X-ray, the patient's posture may vary, often lying on the table in either a supine or lateral position to capture views of the vertebrae in the lower back (lumbar spine). Patients may be asked to remain very still, or even hold their breath momentarily, to prevent motion blur, which can obscure important details. Both hip and spine X-rays are quick and painless, generally taking only a few minutes, with the X-ray exposure itself lasting less than a second.
Eligibility Criteria
The study population comprises individuals presenting for DEXA scans at the Ibn Sina Diagnostic Centre in Uttara. These patients are either referred by orthopaedic specialists and radiologists due to orthopaedic issues, such as back pain, or are attending routine check-ups, particularly postmenopausal women or individuals with other risk factors. The study includes subjects with varying bone densities, as measured by DEXA scans, which serve as the gold standard for Bone Mineral Density (BMD) assessment. Participants will include adults aged 18 and above, of any gender, with available X-ray imaging of relevant skeletal sites, such as the spine and hip. They are required to provide informed consent for the use of their X-ray images and clinical data in the study. Additionally, participants must have both X-ray and DEXA scan results, along with supplementary medical records when available.
You may qualify if:
- Female and male patients aged 18 and above
- Individuals willing to participate and who have provided informed consent for the use of their X-ray images and clinical data for research purposes.
- Subjects with both X-ray images of hip and spine and DEXA scan results.
- Accessibility to supplementary medical records that may contribute to the model's predictive accuracy, such as historical data on fractures, pregnancies, relevant medical conditions and other osteoporosis-related factors.
You may not qualify if:
- Subjects for whom X-ray images or clinical data are incomplete or of insufficient quality for analysis.
- Individuals with medical conditions that could significantly alter bone density independently of osteoporosis, such as bone cancers or certain metabolic diseases.
- Subjects who have undergone treatments or procedures that might significantly impact bone density measurement, such as long-term steroid use or recent orthopaedic surgeries.
- Pregnant women, given the potential impact on screening results and the need for special considerations during pregnancy.
- Patients with implant in hip or spine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ibn Sina Diagnostic Centre, Uttara
Dhaka, 1230, Bangladesh
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Taufiq Hasan, PhD
Department of Biomedical Engineering, Bangladesh University of Engineering and Technology (BUET), Dhaka - 1205.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 16, 2024
First Posted
October 22, 2024
Study Start
September 12, 2024
Primary Completion
March 12, 2025
Study Completion
March 12, 2025
Last Updated
October 22, 2024
Record last verified: 2024-10